This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Trials

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

New Once-daily Treatment for Type 2 Diabetes

Posted: Wednesday, July 15, 2009

A new treatment for Type 2 diabetes may soon be a reality in the U.S.. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk's latest brain child and has been approved by the E.U.

Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation

Posted: Tuesday, June 30, 2009

Just as in the Accord study and in the Avandia debacle controversy, premature release of this kind of information before all the facts are in can be devastating for the medical community and patients. They will tell patients to consult with their physicans before making any changes to their treatment. But what can their physician tell them when they have not had any time to analyze the data and the information is not conclusive and more studies are needed?

This premature release states that Sanofi-Aventis's diabetes drug Lantus may increase the risk of cancer, according to European studies involving some 300,000 insulin-treated patients, prompting a call from experts for more research.

Body Chemistry Identifies Type 2 Risk

Posted: Tuesday, June 30, 2009

Researchers studying 6,538 people in the UK over almost 10 years found specific changes in blood glucose levels and sensitivity to the hormone insulin.

New Possible Bone Marrow Stem Cell Therapy for Diabetes

Posted: Wednesday, June 24, 2009

Dr. Aaron Vinik, principle investigator for the study at Eastern Virginia Medical School in Norfolk, is testing a new diabetes drug, Prochymal. It’s part of a first-of-its-kind study for finding a possible cure.

Cancer Patients May Benefit from Diabetic Drug

Posted: Saturday, June 20, 2009

Metformin, a widely used anti-diabetic drug, has the effect of making cancer therapies and vaccines more effective by boosting the immune system, according to a recently published study.

Once-Weekly Exenatide Provides Glycemic Control and Weight Loss

Posted: Wednesday, June 17, 2009

Once-weekly exenatide (EQW) produces superior improvements in glucose control and body weight compared with maximum daily doses of sitagliptin and pioglitazone on background metformin, according to study results presented at the ADA 69th Scientific Sessions.

Inhaled Insulin AFRESA(R) Controls Post-Meal Sugar Levels with Less Weight Gain and Hypoglycemia

Posted: Wednesday, June 17, 2009

The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes.

Three New Weight-Loss Drugs Show Benefits for Diabetics

Posted: Wednesday, June 17, 2009

Three investigational diet drugs hold promise for preventing and treating diabetes. The findings show that the drugs can help "halt the progression towards Type 2 diabetes.

GLP-1 Liraglutide Versus Sulfonylureas

Posted: Wednesday, June 17, 2009

Novo Nordisk experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.

New Fluorescent Technology for Glucose Sensors are Accurate

Posted: Wednesday, June 17, 2009

A novel continuous glucose monitor that uses fluorescence to provide a read-out of blood sugar appears to be accurate, especially in the hypoglycemic range, researchers said at ADA.